首页> 外文OA文献 >Sodium glucose cotransporter 2 inhibitors and risk of major adverse cardiovascular events: multi-database retrospective cohort study

【2h】

Sodium glucose cotransporter 2 inhibitors and risk of major adverse cardiovascular events: multi-database retrospective cohort study

机译：葡萄糖COTRANSPORTER 2抑制剂和主要不良心血管事件的风险：多数据库回顾队列研究

代理获取

本网站仅为用户提供外文OA文献查询和代理获取服务，本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文，但由于OA文献来源多样且变更频繁，仍可能出现获取不到、文献不完整或与标题不符等情况，如果获取不到我们将提供退款服务。请知悉。

页面导航

著录项
引文网络
相似文献
相关主题

著录项

作者
Kristian B Filion; Lisa M Lix; Oriana HY Yu; Sophie Dell’Aniello; Antonios Douros; Baiju R Shah; Audray St-Jean; Anat Fisher; Eric Tremblay; Shawn C Bugden; Silvia Alessi-Severini; Paul E Ronksley; Nianping Hu; Colin R Dormuth; Pierre Ernst; Samy Suissa;
展开▼
作者单位

展开▼
年度 2020
总页数
原文格式 PDF
正文语种
中图分类

相似文献

外文文献
中文文献
专利

1. Cardiovascular Outcomes and Risks After Initiation of a Sodium Glucose Cotransporter 2 Inhibitor Results From the EASEL Population-Based Cohort Study (Evidence for Cardiovascular Outcomes With Sodium Glucose Cotransporter 2 Inhibitors in the Real World) [J] . Udell Jacob A., Yuan Zhong, Rush Toni, Circulation: An Official Journal of the American Heart Association . 2018,第14期

机译：发起葡萄糖Cotorancorper 2抑制剂的心血管结果和风险来自基于画架群体的群组研究（葡萄糖Cotorangerporter 2抑制剂在现实世界中的心血管结果证据）
2. Comparison of the Effects of Glucagon-Like Peptide Receptor Agonists and Sodium-Glucose Cotransporter 2 Inhibitors for Prevention of Major Adverse Cardiovascular and Renal Outcomes in Type 2 Diabetes Mellitus Systematic Review and Meta-Analysis of Cardiovascular Outcomes Trials [J] . Zelniker Thomas A., Wiviott Stephen D., Raz Itamar, Circulation: An Official Journal of the American Heart Association . 2019,第17期

机译：胰高血糖素样肽受体激动剂和钠 - 葡萄糖COT转折剂2抑制剂预防2型糖尿病系统审查和荟萃分析的糖尿病患者抑制剂预防糖尿病的重大不良心血管和肾外转移的影响
3. Letter by Taegtmeyer and Karlstaedt Regarding Article, "Lower Risk of Heart Failure and Death in Patients Initiated on Sodium-Glucose Cotransporter-2 Inhibitors Versus Other Glucose-Lowering Drugs: The CVD-REAL Study (Comparative Effectiveness of Cardiovascular Outcomes in New Users of Sodium-Glucose Cotransporter-2 Inhibitors)" [J] . Taegtmeyer Heinrich, Karlstaedt Anja Circulation: An Official Journal of the American Heart Association . 2018,第9期

机译：Taegtmeyer和Karlstaedt关于文章的信，“在钠 - 葡萄糖Cotoransporter-2抑制剂与其他葡萄糖降低药物中发起的患者的患者风险和死亡风险：CVD-Real研究（钠新用户的心血管结果的比较有效性 -Glucose COTRANSPORTER-2抑制剂）“
4. Identifying Patients at Risk of Major Adverse Cardiovascular Events Using Symbolic Mismatch [C] . Zeeshan Syed, John Guttag Annual conference on Neural Information Processing Systems . 2011

机译：使用符号不匹配来识别有重大心血管不良事件风险的患者
5. Risk of major adverse cardiovascular events with in-stent restenosis of bare metal stents. [D] . Mahapatra, Ena. 2010

机译：裸金属支架支架内再狭窄会导致重大不良心血管事件的风险。
6. Use of sodium glucose cotransporter 2 inhibitors and risk of major cardiovascular events and heart failure: Scandinavian register based cohort study [O] . Björn Pasternak, Peter Ueda, Björn Eliasson, 2019

机译：葡萄糖共转运蛋白2抑制剂的使用和重大心血管事件和心力衰竭的风险：基于斯堪的纳维亚注册的队列研究
7. Major adverse cardiovascular and limb events in patients with diabetes and concomitant peripheral artery disease treated with sodium glucose cotransporter 2 inhibitor versus dipeptidyl peptidase-4 inhibitor [O] . Hsin-Fu Lee, Shao-Wei Chen, Jia-Rou Liu, 2020

机译：糖尿病患者的主要不良心血管和肢体事件，糖醋酸钠对葡萄糖酸钠2抑制剂与二肽基肽酶-4抑制剂治疗

Sodium glucose cotransporter 2 inhibitors and risk of major adverse cardiovascular events: multi-database retrospective cohort study

著录项

引文网络

相似文献

相关主题

期刊订阅